Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Removing the thymoma improved the patient's alopecia areata, suggesting a possible link between the two.

Entospletinib effectively prevents eye and skin GVHD in mice.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Biological therapy boosts the immune system to effectively fight melanoma.

KLHL24-mutant stem cells help understand skin and heart disease.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

RXRα is crucial for proper immune response and links diet to immune function.

Ayurveda treatments may effectively manage sub-clinical hypothyroidism symptoms.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Thymectomy and high-dose prednisolone improved hair loss in a woman with alopecia areata.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.